ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ADARx Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. ADARx Pharmaceuticals Inc. market cap is $2B.
What is the 52-week high for ADARx Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ADARx Pharmaceuticals Inc. 52 week high is $23.21 as of October 02, 2026.
What is the 52-week low for ADARx Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ADARx Pharmaceuticals Inc. 52 week low is $17.00 as of October 02, 2026.
What is ADARx Pharmaceuticals Inc. stock price today?
ADARx Pharmaceuticals Inc. stock price today is $18.25.
What was ADARx Pharmaceuticals Inc. stock price yesterday?
ADARx Pharmaceuticals Inc. stock price yesterday was $19.54.
What is the Price-to-Book ratio of ADARx Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. ADARx Pharmaceuticals Inc. P/B ratio is -8.3126.
What is the 50-day moving average of ADARx Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. ADARx Pharmaceuticals Inc. 50-day moving average is $19.43.